(Q47692308)

4 February 2018

title

A placebo-controlled, randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful (English)

1 reference

4 February 2018

0 references

1 reference

Schade DS

1

1 reference

4 February 2018

Jovanovic L

series ordinal

2

1 reference

4 February 2018

Schneider J

series ordinal

3

1 reference

4 February 2018

publication date

1 July 1998

1 reference

4 February 2018

The Journal of Clinical Pharmacology

published in

1 reference

4 February 2018

volume

38

1 reference

4 February 2018

issue

7

1 reference

4 February 2018

page(s)

636-641

1 reference

4 February 2018

Cationic and Secretory Effects of Glimepiride and Glibenclamide in Perifused Rat Islets

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

Pancreatic and extrapancreatic sulfonylurea receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

Acute actions of sulfonylurea drugs during long-term treatment of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

A general overview of Mantel-Haenszel methods: applications and recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

Clinical profile of glimepiride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

Atherosclerosis in diabetes: the role of hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04471.X

10.1002/J.1552-4604.1998.TB04471.X

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018